Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 4/24/2013 9:42:50 AM : Underperform Start Price: $2.21 LXRX Score: +9.70

too many achilles heals for a big run up now

Featured Broker Partners


Advertisement